Trials / Completed
CompletedNCT06962826
A Study in Healthy People to Test How Empagliflozin is Taken up in the Body When Taken as a Whole Tablet or Dissolved in Water and Mixed With Food
Relative Bioavailability of Empagliflozin Tablets After Different Administration Modi in Healthy Male and Female Subjects (Randomised, Two-period Crossover Study)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This trial is conducted to test how empagliflozin is taken up in the body when taken as a whole tablet or dissolved in water and mixed with food.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Empagliflozin | Empagliflozin |
Timeline
- Start date
- 2025-05-27
- Primary completion
- 2025-06-26
- Completion
- 2025-09-12
- First posted
- 2025-05-08
- Last updated
- 2025-09-18
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT06962826. Inclusion in this directory is not an endorsement.